Peloton Wealth Strategists Purchases 6,039 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Peloton Wealth Strategists increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating) by 201.2% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 9,041 shares of the medical equipment provider’s stock after buying an additional 6,039 shares during the period. Peloton Wealth Strategists’ holdings in Intuitive Surgical were worth $3,248,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in ISRG. Edgewood Management LLC raised its stake in Intuitive Surgical by 200.2% during the third quarter. Edgewood Management LLC now owns 8,528,553 shares of the medical equipment provider’s stock worth $2,826,220,000 after buying an additional 5,687,456 shares during the last quarter. Fisher Asset Management LLC raised its stake in Intuitive Surgical by 215.3% during the fourth quarter. Fisher Asset Management LLC now owns 4,313,145 shares of the medical equipment provider’s stock worth $1,549,713,000 after buying an additional 2,945,104 shares during the last quarter. Baillie Gifford & Co. raised its stake in Intuitive Surgical by 191.5% during the fourth quarter. Baillie Gifford & Co. now owns 4,401,406 shares of the medical equipment provider’s stock worth $1,581,425,000 after buying an additional 2,891,713 shares during the last quarter. Northern Trust Corp increased its stake in Intuitive Surgical by 200.2% in the fourth quarter. Northern Trust Corp now owns 3,911,386 shares of the medical equipment provider’s stock valued at $1,405,362,000 after purchasing an additional 2,608,267 shares in the last quarter. Finally, Brown Advisory Inc. increased its stake in Intuitive Surgical by 199.6% in the fourth quarter. Brown Advisory Inc. now owns 3,157,019 shares of the medical equipment provider’s stock valued at $1,134,318,000 after purchasing an additional 2,103,350 shares in the last quarter. 83.69% of the stock is owned by institutional investors and hedge funds.

Several research firms have weighed in on ISRG. Evercore ISI decreased their price target on shares of Intuitive Surgical from $294.00 to $280.00 in a research note on Friday, April 22nd. Stifel Nicolaus decreased their price target on shares of Intuitive Surgical from $370.00 to $325.00 and set a “buy” rating for the company in a research note on Friday, January 21st. Royal Bank of Canada began coverage on shares of Intuitive Surgical in a research note on Friday, March 25th. They issued an “outperform” rating and a $340.00 price target for the company. Zacks Investment Research cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $257.00 price objective for the company. in a report on Wednesday, April 27th. Finally, UBS Group upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $317.00 to $325.00 in a report on Wednesday, February 2nd. Eight analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $326.60.

Intuitive Surgical stock traded up $12.00 during midday trading on Friday, reaching $223.69. 2,250,282 shares of the stock were exchanged, compared to its average volume of 2,675,108. The company’s fifty day moving average is $269.05 and its 200-day moving average is $303.94. The firm has a market cap of $80.30 billion, a PE ratio of 49.75, a PEG ratio of 4.81 and a beta of 1.26. Intuitive Surgical, Inc. has a 52 week low of $206.60 and a 52 week high of $369.69.

Intuitive Surgical (NASDAQ:ISRGGet Rating) last issued its quarterly earnings results on Thursday, April 21st. The medical equipment provider reported $1.00 EPS for the quarter, topping analysts’ consensus estimates of $0.93 by $0.07. The firm had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.43 billion. Intuitive Surgical had a net margin of 27.84% and a return on equity of 14.16%. The business’s revenue for the quarter was up 15.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.17 EPS. As a group, analysts forecast that Intuitive Surgical, Inc. will post 4.14 EPS for the current year.

In other news, EVP Myriam Curet sold 2,478 shares of the stock in a transaction on Wednesday, February 16th. The shares were sold at an average price of $289.00, for a total value of $716,142.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.90% of the stock is owned by corporate insiders.

About Intuitive Surgical (Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Read More

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.